A certain analyst, whose name shall remain unuttered (lest we grant him undue fame), dares to whisper that Ethereum’s revival is but a fleeting illusion. “A multi-month downtrend,” he murmurs, as if reciting a dirge. How dramatic! 🦉✨ And yet, one must admit, his caution is not entirely unwarranted. The $4,000 threshold looms like a sphinx, its riddle unsolved, its claws poised to strike.
Stadelmann also blamed the economy, because of course he did. “Macroeconomic uncertainty” is just a fancy way of saying, “We’re all winging it.” Meanwhile, Bitcoin ventures are like that one friend who insists on paying in cash-no VCs needed, thanks to their bootstrapping, community-loving ways. Gabe Salinas, CEO of Alamo Labs, put it best: “Bitcoin doesn’t need your fancy VC money. It’s got its own fan club.” 🎩✨
The ancient adage “buy low, sell high” is like a witch’s broomstick: everyone knows it’s the answer, but few question whether the question makes sense. Rule Breakers, however, prefer to “add up, don’t double down”-a strategy that sounds like advice from a gamblers’ guild but is, in fact, a masterstroke of psychological alchemy. By focusing on buying more of your winners rather than sweating the sale, Gardner suggests we should “buy high and try not to sell”2. It’s the financial equivalent of telling a dragon you’re not interested in its treasure-but then accepting it anyway because you’re too polite to refuse.
Consider the arithmetic of elegance: NUANCE’s stake now rests at 314,208 shares, a $20.85 million bauble that adorns just 2.1% of their $982.15 million portfolio. To sell thirty-eight million may be considered prudent; to retain twenty seems positively romantic. The position’s contraction from 5.6% to 2.12% of AUM reads like a financial villanelle – each line a measured diminuendo.
By the somber decree of legal documents, the fund’s representatives, ensnared in bureaucratic coils, disposed of a quantity of shares that collectively represented a mere fragment-3.3%-of their prior grasp, halving the apparent stakes in a game governed by precios and timing no one fully understands. The transaction, executed within the opaque corridors of the quarter’s pricing averages, concluded at a figure nearing eight million dollars, a sum that, like most things in this labyrinth, appears to fluctuate wildly between significance and insignificance, especially once cloaked in the fog of market sentiment.
Ah, Monday-the day ICP decided to send its investors into a frenzy. The token took a dramatic 11.2% plunge to $6.69, smashing through the sacred $7.00 support level as though it were an obstacle in an absurdist play. It was like a well-scripted tragedy, complete with a surprise twist: the decline has been steadily unfolding for the past week, a perfect follow-up to the previously “hopeful” $8.76 rally. Alas, the fairytale didn’t last long-ICP’s descent was the stuff of nightmares. CoinDesk’s technical research (bless them) tells us this was one of the sharpest drops seen in months. Maybe next time, ICP, try a more graceful exit.
On Tuesday, Stellar’s XLM token-ever the drama queen-rose 3.62% to $0.3004, making a showy break above key resistance. The volume? Well, it soared nearly 19% above its 30-day average, as if to announce to the world, “I’m here to stay!” This move put XLM ahead of the broader crypto market by 4.86%, nudging it closer to the 5% relative strength threshold. That magic number, of course, is often the harbinger of a breakout that leaves us all holding our breath.
The fund, that ever-eager collector of stocks, quietly revealed it bought a hefty chunk of Dentsply during the third quarter ending September 30, 2025. Multiplied by a million, it means gaining more than 1.5 million shares, pushing their total to over 1.5 million, worth roughly $19.34 million at the close of that financial quarter. Now, those shares make up about 13.5% of Brickwood’s U.S. equity meatloaf. An impressive appetite for a company with a track record that would give even the most optimistic investor pause.
The Chicago-based alchemists at Readystate recently filed Form 13F with the SEC, revealing their new position in Workiva. This constitutes 2.43% of their U.S. equity holdings – a figure that sounds more impressive until you realize they hold 301 other securities. Like a gambler spreading chips across a rigged roulette table, they’ve bet 1.36% of their $2.35 billion AUM on a software outfit whose stock has been playing dead man’s float against the S&P 500.
The transaction, recorded with the solemnity of a coroner’s report, reduced the fund’s exposure by precisely 100,461 shares during the third quarter. This surgical reduction left 245,581 shares trembling in the cold embrace of market forces, now valued at $14.6 million-a sum that would soon prove more theoretical than actual.
